Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Albrecht Stenzinger
Affiliation
Institute of Pathology, University Hospital Heidelberg
ORCID
Career Start Year
2005
Papers
415
H Index
58
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37872280
Integrated genotype-phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas.
Virchows Arch
2024
37558578
Erratum to "Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project": [Annals of Oncology 32 (2021) 1626-1636].
Ann Oncol
2024
36379463
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Z Gastroenterol
2023
37562657
Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.
Gastroenterology
2023
37525239
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
J Ovarian Res
2023
37957250
Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer.
Sci Rep
2023
37657453
[Molecular tumor diagnostics as the driving force behind precision oncology].
Dtsch Med Wochenschr
2023
37894418
Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
2023
37792098
[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology].
Pathologie (Heidelb)
2023
37586177
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Lung Cancer
2023
37548948
[Testing deficient mismatch repair and microsatellite instability : AÂ focused update. German version].
Pathologie (Heidelb)
2023
37507610
Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability.
Eur Radiol
2023
37544709
Tumour mutational burden and survival with molecularly matched therapy.
Eur J Cancer
2023
37608772
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
2023
37608771
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
2023
37874379
Testing for deficient mismatch repair and microsatellite instability : AÂ focused update.
Pathologie (Heidelb)
2023
37641393
Precision cancer medicine: Concepts, current practice, and future developments.
J Intern Med
2023
37639843
Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
Eur J Radiol
2023
37391339
Pembrolizumab Alone or With Chemotherapy for 70+ Year-Old Lung Cancer Patients: A Retrospective Study.
Clin Lung Cancer
2023
37059713
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.
Cell Death Discov
2023
37058788
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations.
Lung Cancer
2023
37058257
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.
Clin Cancer Res
2023
37455247
Implementation of precision medicine in healthcare-A European perspective.
J Intern Med
2023
37280276
The German Network for Personalized Medicine to enhance patient care and translational research.
Nat Med
2023
37141769
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Lung Cancer
2023
37371836
An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS).
Biomedicines
2023
37371827
Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia.
Biomedicines
2023
37238245
Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy.
Diagnostics (Basel)
2023
37205635
The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.
Cancer Res
2023
37068173
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Cancer Discov
2023
37331287
Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
Eur J Radiol
2023
36961477
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Oncologist
2023
37327584
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
Transl Oncol
2023
37260092
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study.
Eur J Endocrinol
2023
36445224
Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners.
Genes Chromosomes Cancer
2023
36852573
Real-world data for precision cancer medicine-A European perspective.
Genes Chromosomes Cancer
2023
36808802
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.
Mol Oncol
2023
36436002
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination.
Clin Res Cardiol
2023
36738930
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC.
J Thorac Oncol
2023
36608320
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
2023
36932239
[The biomarker PIK3CA in tumor pathology].
Pathologie (Heidelb)
2023
36735063
Structure and content of the EU-IVDR : Current status and implications for pathology.
Pathologie (Heidelb)
2023
36635225
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.
J Pathol Clin Res
2023
36562826
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.
Cancer Immunol Immunother
2023
36726983
Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.
Front Immunol
2023
36372281
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
2023
36170665
FGFR2 Inhibition in Cholangiocarcinoma.
Annu Rev Med
2023
34331337
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Genes Chromosomes Cancer
2022
35384413
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
J Pathol Clin Res
2022
35763870
Gene expression-based prediction of pazopanib efficacy in sarcoma.
Eur J Cancer
2022
1 - 50 of 415
Column Actions
Search
Recommended Authors
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year
2015
Number of shared co-authors
16
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year
2012
Number of shared co-authors
2
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year
2011
Number of shared co-authors
2
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year
2009
Number of shared co-authors
29
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
13
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year
2008
Number of shared co-authors
2
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
4
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
9
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
5
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
5
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
17
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year
2006
Number of shared co-authors
1
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
5
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
5
Sherri Z Millis
Foundation Medicine Inc
Career Start Year
2003
Number of shared co-authors
3
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
29
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
10
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
33
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
3
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year
2002
Number of shared co-authors
10
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
5
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
15
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
0
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
9
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year
1999
Number of shared co-authors
14
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
13
Siraj M Ali
Foundation Medicine
Career Start Year
1995
Number of shared co-authors
16
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
2
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
19
row(s) 1 - 30 of 30
Collaborators
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
126
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
100
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers
72
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
70
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers
60
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers
59
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
55
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers
54
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers
37
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers
35
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
34
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers
31
Barbara Hutter
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers
24
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers
23
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers
23
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers
19
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers
18
Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Co-authored papers
16
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
15
Matthias Schlesner
University of Augsburg
Co-authored papers
13
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers
12
Andreas von Deimling
Co-authored papers
11
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers
11
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
10
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers
10
Michael Bockmayr
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers
9
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Co-authored papers
8
Stephanie Roessler
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
8
Stephan Wolf
Co-authored papers
8
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers
8
1 - 30